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T his d iscussion will focus on the pathogenesis of chronic wounds and on certain aspects of their biology that in our opinion ~ese rve further investi-gative effo rts. Three prototypic chromc wounds will be ;lI1aJyzed: decubitus (pressure), diabetic, and 
venoUs ulce rs. 
P ATHOGENESIS OF C HRONIC WOUNDS 
P bitus (Pressure) Ulcers Pressure ulcers are characterized 
b ~d~ep tissue necrosis and loss of v? lume that are disproportion-
Y I great e r than the overlying skl11 defect . PromlI1ent chmcal 
,re y ts of these features are th e undermined edges of the ulcerations ~!ct~he frequent underestimation of the total size of the ulcers from 
measur em e nts o f sudace changes alone. The pressure-Induced cone 
ofinj ury d escribed by Reuler.and Coone
l
Y.[1] h~s Its basle toward thde 
Dl1derlying bone. T o a certau
d
1 extent, t l1S preb1erde.ntla mUSIC e ~n 
bcu taneous ir~jury may be ue to pressure y Irect or s leafin g ~u ces o n la rge segmental and perforator arteries, whereas the skin ~ more opportunity to maintain blood supply from nearby anasto-
mosing vessels. Howeve:, other intrinsic factors may playa role in 
ferentia l muscle 11llUry. Muscle fibers show degenerative 
Ph
c 
nges afte r as little as 60 mm H g of contact pressure applied over a ~'h period. In contras t, it requires as much as 600 mm H g over 11 h 
~ue to space limitations, not all ~pplic.able references could be included in 
!his review. A full list of references IS avaIlable fro~n the author upon request. 
Reprint requests co: Dc V1I1cent Falan ~a,. ASSOCIate Professor of Derma to 1-
ogy UniversIty of MIamI School of MedlC1l1e, Department of Dermatology 
Ili Cutaneous Surgery, Miami, FL 33136. 
Abbreviat ions: 
f\TP: adenosine triphosphate 
EG F: epidermal growth fac tor 
PDGF: platelet-deri ved growth factor 
TGF: t ransforming growth facto r 
before full-thickness necrosis develops in pig skin [2]. Ischemia 
from pressure is also closely linked to anatomic location. Thus, 
although the mid-capillary pressure is only about 20 mm Hg, the 
forces of compression over the body surface are not uniform and can 
reach as much as 2600 mm H g over bony prominences [3]' It has 
been found that both the degree and duration of pressure necessa.ry 
to cause necrosis and ulceration are important variables. Thus, 
100 mm H g of pressure applied to the skin of rats for 2 to 10 h 
produces an increasing spectrum of muscle damage and necrosis (see 
[2] for a review). Consistent with the clinical experience in humans, 
experimental necrosis-induced pressure has been found to occur 
more rapidly and with less pressure in animals with a pre-existing 
neurologic or vascular deficit. 
The pathogenic steps leading to ulceration after pressure injury 
have not been inves ti gated in detail, but important clues are avail -
able from related work. It is generally accepted that the total tissue 
pressure is normally zero, the end result of negative interstitial and 
positive solid tissue pressures. The application of an external force 
may cause the interstitial pressure to rise and exceed the 12 mm H g 
present in the venous capillary limb; the end result is a rise in the 
total tissue pressure, increased capillary filtration, edema, and cell 
autolysis. At the same time, the lymphatic channels are occluded 
because of the increase in tissue pressure, leading to further edema 
and autolys is [1]. Persistent occlusion of vessels may also be an 
important aspect of the pathogenesis of pressure il~ury. An altered 
state of fibrinolysis fo llows periods of ischemia, perhaps due to 
endothelial cell damage and epidermal injury [4]. Fibrin thrombi are 
in fact not an uncommon histologic finding in pressure ulcers. In 
experimental lung injury, it has been found that only partial restora-
tion of blood flow fo llows relief of unilateral pulmonary artery 
occlusion, and that this is the result of neutrophil adhesiveness to 
the endothelium [5] . Similar mechanisms may be operative in the 
skin and subcutaneous tissues after prolonged ischemia. ~oreover , 
following the resumption of normal perfusion in ischemiC models, 
reactive oxygen species are generated that are now ~nown to dam-
age enzymatic proteins as well as nucleic acids and lipids [6]: These 
pathophysiologic considerations offer therapeutic opportumtles by 
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fibrinolytic enhancement, by altering endothelial-neutrophil adhe-
sion, and by the use of antioxidants. 
Pharmacologic interventions in experimental models of ischemia 
or pressure injury have shed lighton other potentially useful mecha-
nisms of pressure necrosis. Various forms of stress or th e injection of 
epinephrine were able to protect rats from ischemic injury, a finding 
that was abrogated in animals given systemic corticosteroids. Sev-
era l studies in skin flap survival have demonstrated tissue preserva-
tion after alpha-adrenergic blockade [4]. Investi gative efforts should 
focus on these and other potential mechanisms of pressure-induced 
cell injury. It is not known whether toxic metabolites are released by 
the injured tissue or whether genes for programmed cell death are 
activated. Answers to these questions could help decrease cellular 
injury initiated by pressure-induced ischemia. 
Venous Ulcers It is widely believed that venous ulceration is the 
result of long-standing venous hypertension, but the pathogenic 
steps involved in this relationship are still speculative. The venous 
system of the lower leg (deep, communicating, and superficial 
veins) contains one-way val~es whose net effect is to prevent retro-
grade blood flow. It is normally not appreciated that the valves are · 
not functiona l when the calf muscles are relaxed but rather are free 
floating; the va lves direct blood only in the presence of a pressure 
differential between the deep and superfi cial venous system. This 
pressure differential becomes operative only during calf muscle 
contraction , which leads to increased deep vein pressure and cepha-
lad emptying of the deep veins. In individuals with normal veins 
and calf muscle function, the action of the calf muscle pump unit 
causes a drop in deep vein pressure that directs blood flow from the 
superficial veins through the communicating veins and into the 
deep veins. Thus, during walking, the leg in contact with the 
ground is undergoing calf muscle pump contraction, deep vein 
emptying, and fall in pressure (systole), whereas the leg about to 
touch ground is undergoing filling of the deep veins from the su-
perficial system (diastole). In a diseased venous system and faulty 
calf muscle pump unit, the predicted fall in venous pressure upon 
ambulation or leg exercise does not occur. The pressure may stay the 
same as before ambulation or fall minimally, a situation that has 
been termed venous hypertension and is often referred to as venous 
insufficiency (see [7] for a review). Venous hypertension is th erefore 
a misnomer, because the venous pressure does not actually increase. 
Venous hypertension is the result of one or several of the following 
abnormalities: faulty communicating and superficial vein valves, 
damage to deep vein valves, deep vein occlusion, and muscle dys-
function or pump failure from fibrosis, neuropathies, inflammatory 
disease. 
It has been proposed that venous hypertension leads to distension 
of the capillary bed and leakage of macromolecules, particularly 
fibrinogen, from the blood into the dermis (see [8] for a review). 
This series of events has been shown to occur in experimenta l 
venous hypertension in the canine hind limb. The fibrinogen that 
leaks into the dermis polymerizes to pericapillary fibrin cuffs that 
presumably lead to ulceration by acting as a barrier to the diffusion 
of oxygen and other nutrients from the vasculature into the dermis. 
The presence of fibrin cuffs in lipodermatosclerotic non-ulcerated 
skin and at the edge of venous ulcers has been repeatedly demon-
strated [9,10]. Recently, Claudy et al [11] have confirmed the pres-
ence of pericapillary fibrin in venous ulcers and shown with specific 
antibodies that fibrin cuffs are composed for the most part of unde-
graded fibrin. These authors have also shown' a dermal accumula-
tion of tumor necrosis factor, which they suggested might playa 
role in venous ulceration. Systemic fibrinolytic and coagulation ab-
normalities in patients with venous disease and ulceration are also 
well established, and they are likely to impair fibrin removal. In 
addition to exhibiting increased plasma fibrinogen levels and eu-
globulin lysis time [8,9], patients with venous disease and ulceration 
have increased levels of fibrin-related anti gens, D-dimer, D-mono-
mer, and fibrin monomer [12]. The elevation of these fibrinolytic 
products strongly suggests increased fibrin formation and break-
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down. It is unclear whether th ese fibrinolytic and coagulation ab-
normalities are primary or secondary to venous disease. However, 
Stacey et al [13] found that dermal pericapillary fibrin deposition 
precedes the development of lipodermatosclerosis. 
But not all is well with the fibrin hypothesis of venous ulceration. 
Specifically, the role of fibrin cuffs as a physical barrier now appears 
unlikely. Firstly, the cuffs are discontinuous around the dermal 
capillary [14], rendering the notion of a barrier less plausible. Sec-
ondly, recent work indicates that ulcers heal in spite of the persist-
ence of fibrin cuffs [10]. Indeed, fibrin and the products released 
during its formation and removal could sti ll playa pathogenic role 
in venous ulceration. For example, although the acute deposition of 
fibrin has been associated with extracellular matrix accumulation ill 
vivo [15], recent investigations in our laboratory (Drs. V. Falanga 
and J. Pardes, unpublished) have shown that fibrin and fibrinopep-
tide B have a direct downregulatory effect on procollagen type 1(1) 
synthesis by dermal fibroblast cultures. Similarly, fibroblasts on fi-
brin gels synthesize less collagen. N evertheless, doubts about the 
pathogenic role of fibrin have suggested other mechanisms for ulcer 
formation . It has been proposed that fibrin deposition, although 
definitely present, is not the result of venous hypertension-induced 
capill ary permeability . Rather, venous hypertension may lead to 
endothelial cell damage, making the endothelial cells more adher-
ent for circulating leukocytes. Presumably, the leukocytes adhere to 
the damaged endothelia l cells and release inflammatory mediarors, 
increasing capillary and vascular permeability [16] and perhaps tis-
sue damage. Others have recently proposed that the accumulation 
of iron in venous disease sets up a Fenton reaction with H 20 2 to 
yield hydroxyl radicals leading to further tissue damage [1 7]. Fi-
nally, a novel hypothesis for venous ulceration has been proposed 
recently that may unify severa l concepts of the pathogenesis. This 
hypothesis suggests that the documented leakage into the dermis of 
macromolecules from the vasculature, including fibrinogen, albu-
min, and alpha-2-macroglobulin, leads to "trapping" of growth 
factors by these proteins: this process would make growth factors 
and perhaps even normal matrix components unavailable to the 
repair process [1 8]. 
Diabetic Ulcers It has long been thought that an intrinsic and 
fundamental step in the pathogenesis of diabetic complications is 
"small vessel disease." In the eloquent words of LoGerfo and Coff-
man [19], this notion has been "a tenacious misconception, still 
repeated by teachers, residents, and students. . . . " The clinical 
implication of this emphasis on sma ll vessel disease is not just aca-
demic, for it leads to inappropriate care and a sense of therapeutic 
pessimism. It is now clear that the on ly histologic vascular abnor-
mality found consistently in prospective studies of diabetic patients 
is excessive thickness of the basement membrane in the muscle. 
Compared to that of normal subjects, the thickness of the basement 
membrane is up to twofold greater in diabetes [20]. A similarl ' 
thickened basement membrane is not a feature of diabetic skin [21] 
although the function of dermal capillary may be altered, as is dem-
onstrated by increased perivascular localization of albumin [22]. In 
fact, other physiologic microvascular abnormalities may exist in 
diabetic patients, and the rejection of the concept of "small vessel 
disease" needs to be confined to the absence of obstructive lesions in 
the microvasculature [1 9]. 
One is still left with a rather formidable triad of neuropath ' 
ischemia, and infection to explain the diabetic ulcer (see [23 ,24] for 
reviews). The clinical result of neuropathy, "insensate foot," leads 
to breakdown of skin after prolonged pressure or minor trauma. 
Failure of motor nerves leads to a net increase in extensor function 
characterized clinically by excessive prominence of metatarsal heads 
and claw-like deformity of the foot. As the biomechanical proper-
ties of the foot are altered, sensory impairment plays an increasino 
role in the development of ulcerations over bony prominences ex-
posed to excessive pressures. Autonomic nerve failure provides yet 
another synergistic abnormality in the development of ulceration by 
causing decreased sweating, as wel l as dry and easily damaged skin. 
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In the absence of vascu lar abnormalities, autonomic nerve failure 
leads to s h unting of blood flow to the skin and away from muscle 
and subcutaneous tissue, which are more sensitive to the effects of 
pressure [19,23,24] (see section on pressure ulcers). 
The pathogenesis of neurologic abnorma lities in diabetes has 
been studied rather extensively (see [25] for a review) . Both animal 
and human studies have shown increased glycogen in neural mito-
chondria, possibly as a result of hypoxia. Nonenzymatic glycosyla-
don leads to aggregation of tubul in and microtubules, thus affecting 
cellular transport properties. Glucose enters normal nerve cell s 
without the aid of insulin, and plays an essential role in the produc-
tion of adenosine triphosphate (ATP). In diabetes, ATP utilization 
and not its production are decreased, most likely because of de-
creased nerve cell concentration of myo-inositol. Because myo-ino-
sitol is a hexose very similar to glucose and because its concentration 
in peripheral nerves is up to a hundredfold greater than in plasma, 
hyperglycemia causes competitive cellular uptake more favorable to 
glucose th~n myo-inosi~ol ~ntry into nerves. D~creased neuronal 
concentratlOn of myo-lI1osltol causes an unpalrlnent in N a/K 
ATPase activity and nerve function as well as probable abnormali-
cies in receptor-mediated responses. In addition, the increased glu-
cose concentration in nerve cells leads to a greater conversion to 
sorbito l by aldose reductase, and finally to higher cellular concen-
[rations of fructose. Although the sorbitol pathway has long been 
implicated in the pathogenesis of neuropathy in diabetes, convinc-
ing evidence is still lacking [25]. 
The vascu lar and neurologic abnormalities in diabetes are proba-
bly closely linked. It was recently found that the development of 
neuropathy is associated with subtle but definite impairment in 
vascular flow [26]. At the microscopic leve l, endoneurial capillaries 
in patient s with neuropathy show endothelial cell proliferation and 
enhanced capillary closure [27]. However, as in dermal vessels, the 
presence of endoneurial albumin suggests increased capillary penne-
ability. Other factors contnbutlllg to the vasculopathy must include 
hyperviscosity, intravascular fibrin deposition, and increased adher-
ence of red blood cell s to the endothelium, as well as the autonomic 
shunting mentioned previously [25]. The overwhelming factor 
causing ischemia in diabetic patients, however, is atherosclerosis, 
which typicall y involves the distal arteries. The prevalence of pe-
ripheral vascular disease in diabeti~ patients is estimated to be 45% 
afrer 20 years of disease. Interestingly, there IS poor correlation 
between segmental limb blood pressure and transcutaneous oxygen 
levels (TcP02) at the same site, suggesting that other local factors 
play a role in poor skin oxygenation. Whether tissue edema is suffi-
cient to explain this discrepancy is not clear [23]. 
Infection plays a substantia l role in the perpetuation of the ulcer-
a[ions [23,24] and is aided by the we ll-established detrimental ef-
fects of diabetes on neutrophil function. Still, even taking into con-
lideration all of the factors discussed, clinical experience seems to 
indicate tha t some essential components of the pathogenesis of these 
ulcerations are sti ll not known. In the words of Pecoraro , a "wound 
healing fail ure" appears to be present in a number of patients in spite 
of optimal medical and surgica l care [23]. Factors to be considered in 
th is failure to heal include cellular effects of sorbitol in the wound, 
faulty inflammatory responses leading to impaired migration of 
neutrophils and macrophages to the wound , abnormalities in the 
release and action of growth factors and neuropeptides. Further 
iDves tigations of these factors will be needed to improve our under-
IUnding of the pathogenesis of diabetic wounds. 
PATHOPHYSIOLOGIC-CLINICAL DILEMMAS 
Each of the three types of chronic wounds discussed above is charac-
rtrized by features specific to the type of wound and the clinical 
!feting. However, issues related to pathogenesis and wound chronic-
'Xj appear to overlap among the various wound types, and severa l of 
rhese pathophysiologic elements have been targeted by common 
therapeutic approaches. Thus, the use of hyperbaric oxygen has its 
rat ionale in the fact that wounds are hypoxic, growth factors are 
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being investigated to stimulate what is conceived to be a dormant 
chron~c wound microenvironment, and occlusive dressings arc used 
to optimIze motst wound healing. 
Hr~oxia It has been stated that the cutaneous need for oxygen is 
m1111111al, and that in fact blood supply to the skin is manyfold 
greater than what is necessary, serving mainly a thermoregulatory 
role [4] . The presence of a low oxygen tension (hypoxia) in chronic 
wou.nds IS well established [9,10)' especially in venous ulceration 
and 11~ ulc.ers due to atherosclerosis and diabetes [23]. The traditional 
teachl11g IS that tIssue hypoxia results in cell death and tissue necro-
~IS; hence the r~tiona1e for the use of hyperbaric oxygen. However, 
It has proved difficult to separate the effects of low oxygen tension 
from other events occurring as a result of ischemia. Indeed, ill vitro 
work suggests the notion that hypoxia by itself may not be responsi-
ble for all the de letenous effects of ischemia. It is well established 
that the proliferation and longevity of fibroblasts are stimulated in a 
low oxygen enVIronment, and recent evidence shows that the clonal 
expansion of these. cel!s does not occur except when the ambient 
oxygen concen.tratlon IS reduced [28]. Cellular synthetic activity is 
also. enhanced 111 hypOXIa. Thus, exposure of macrophages to hy-
pOXIC condItions leads to the preferential secretion of an angiogenic 
substance [29], whereas dermal fibroblasts and endothelial cells simi-
larly made hypoxic show upregulation of transforming growth fac-
tor (TGF)-beta 1 PO] and platelet-derived growth factor (PDGF) B 
~hal11 [31), resI?ectlvely. The transcription of alpha 1(1) procollagen 
IS upregulated 111 fibroblast cultures subjected to prolonged hypoxia, 
an effect that I.S partly due to the secretion ofTGF-beta (Falanga V, 
1992, unpubltshed). One might argue that molecular oxygen is 
needed for the hydroxylation of proline, and that collagen synthe-
Sized by hypOXIC cells IS underhydroxylated (32) ; in an hypoxic 
envIronment underhydroxylated collagen accumulates intracellu-
:arly and would flrobably be degraded once secreted. However, the 
~yp~xla present 111 chronic wounds may not be constant, and hy-
poxia ~ay serve as an important intermittent stimulus for collagen 
syntheSIS; return of the oxygen tension to normal or near normal 
levels would allow hydroxylation of the preformed collagen. 
Taken t?gether, these data suggest caution in the interpretation 
that chro111c wounds necessarily benefit from the administration of 
0:cygel~ and argue for further explanation of irr "itro and ill lIillO 
bIOlogIC consequences of hypoxia. Weare not suggesting that 
wounds be made hypOXIC because of the stimulatory effects of low 
oxy~en tensIOn 111 cu ltured ce lls. Rather, given the extensive body 
of Itterature on oxygen free radical formation and its deleterious 
effects on multiple cellular processes [6), optimal oxygen concen-
tratIOns ma~ be. needed to strike a balance between tissue injury, 
cellular repltcatlon, and the synthesis of appropriate amounts and 
qualtty of matnx matenal. 
Failure ~f Re-Epithelialization Impaired re-epithelialization 
charactenzes nuny chronic wounds, although in none is this more 
eVIdent than 111 venous ulceration; resurfacing of these wounds may 
fad to occur for ~nonths , whereas the overall appearance of the 
wound bed remallls unchanged. Even on light microscopy, the 
proml11ent acanthosis regularly present at the edges of venous ulcers 
suggests that epidermal migration rather than proliferation has 
faded [33). Indeed, in studies of venous ulcers and other chronic 
w~unds,. the edge of the ulcerations show features of a regenerative 
epldefl111s [33) defined by overexpression of cell-associated TGF-al-
pha and epidermal growth factor (EGF) receptors as well as the 
presence of filaggrin, involucrin, and AEl keratin [34) . These find-
1I1gs add to the notion that epidermal migration is not normal. 
However, most of the lessons we have learned with regard to epi-
dermal migration have either been obtained from il1 lIitro studies or 
from .models of acute wounds [35]. An important observation is that 
kerat1l10cytes fai l to migrate on a substrate of laminin but do so 
readily when in contact with fibronectin as well as dermal intersti-
tial and basement membrane -specific collagen [36]. At leas t for 
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fibronectin-mediated keratinocyte migration, recognition of the 
Arg-Gly-Asp (RGD) moiety appears to be essential [36,37]. The 
complexities of keratinocyte ad hesion and migration are evident 
from recent studies examining the effect of antibodies that recog-
nize integrin subunits. Thus, it appears that the alpha-3 - beta-l 
receptor is associated with cell immobility, whereas the alpha-2-
beta-1 receptor may enh ance migration on collagen but not on 
fibronectin l38]. When one is able to separate the proliferative stim-
ulation of peptides from their effects on keratinocyte locomotion, it 
appears that for the most part migration is not enhanced by such 
potent growth factors as EGF, TGF-alpha, and TGF-beta [36] . 
The composition of the wound bed in chronic wounds is not 
known, and a clinically "inadequate" chronic wound bed, lacking 
the ideal granulation tissue observed in acute wounds, nevertheless 
may support spontaneous re-epithelialization and autologous grafts. 
Keratinocyte migration is also dependent on the dermal effects and 
the release of peptides from blood-borne cel ls, particularly macro-
phages. It was recently shown that the migration of mononuclear 
cells into acute wounds is a,tightly regulated process with precise 
molecular interactions dependent on endothelial-mononuclear cell 
adhesion [39,40] . The increasing soph istication in our knowledge ' 
of endothelial cell ad hesive interactions has not yet been applied to 
chronic wounds. A new set of rules for matrix formation, keratino-
cyte and macrophage migration, and cell-matrix interactions may 
be operative in the chronic wound. Unraveling these features of the 
chronic wound microenvironment represents an exciting chal-
lenge. 
Wound Fluid Wound fluid reflects the microenvironment of 
the wounds from which it is collected and thus may offer clues to 
the events occurring during wound repair or its failure. Secondly, 
therapeutic agents come in contact with this fluid, and it is impor-
tant to know as much as we can about their possible interactions. 
Thirdly, wound fluid accumulates under occlusive dressings; 
whether this is desirable and whether its partial or complete re-
moval could improve the effectiveness of occl usion and hasten heal-
ing is not known. The importance of studying wound fluid must be 
tempered by the difficulties inherent in its collection and investiga-
tion: type of wound and clinical phase, method of fluid collection, 
its storage and filtration, presence of endotoxins and proteases, and 
general interpretation of experimental findings. 
Many animal studies indicate that fluid taken from acute wounds 
contains a number of growth factors and exhibits cell-stimulatory 
activities, including chemotaxis [41], mitogenesis [42,43], and the 
abi lity to stimulate matrix formation [43] . Human wound fluid 
from beneath a polyurethane dressing used to treat split-thickness 
donor sites was recently shown to stimulate the proliferation of 
fibroblasts and endothelial cells, in part as a result of PDGF in the 
fluid [44] . Findings obtained with fluid from chronic wounds are 
somewhat contradictory. Alper et al [45] reported that fluid col-
lected from venous ulcers covered with a vapor-permeable mem-
brane was stimulatory to dermal fibroblast proliferation in vitro 
when combined w ith serum, although the addition of chronic 
wound fluid without serum caused disruption of the cell monolayer. 
Recently, Grinnell et al [46] have shown that a similarly collected 
wound fluid from venous ulcers contains degraded fibronectin and 
vitronectin, which may affect cellular adhesion to the substratum. 
Wound fluid from venous ulcers also inhibits fibroblast DNA syn-
thesis and, when combined with serum, fails to stimulate or de-
creases the froliferation of fibroblasts, endothelial cells, and kerati-
nocytes [47 . Fractionation of the wound fluid indicates that most of 
the inhibitory activity resides in a fraction less tha.n 30 kD in molec-
ular weight [47,48]. Taken together, these studies have led to the 
hypothesis that the chronic wound fluid, perhaps a reflection of the 
chronic wound microenvironment, is hostile to chronic wound re-
pair. Reconciling the inhibitory effects of chronic wound fluid with 
the beneficial effects of occlusion is not altogether impossible. Oc-
clusion provides a moist environment that may facilitate epidermal 
migration [49], and it alters the inflammatory cells recruited into the 
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wound [40]. Occlusion maintains an important electrical gradient 
across the wound. Moreover, the formation or retention of wound 
exudate under the dressing facilitates debridement [58]. These ben-
eficial events may partially offset the inhibitory effects of the fluid 
itself. 
CONCLUSION 
For the three prototypic chronic wounds discussed, the fundamen-
tal clinical problem is generally loss of subcutaneous tissues (pres-
sure, decubitus ulcer), failure of re-epithelialization (venous ulcer) , 
and the stubborn combination of necrosis and infection (diabetic 
ulcer). However, there are overlaps among these wounds for severa.l 
pathogenic aspects, including pressure injury, hypoxia, fibrin for-
mation and fibrinolysis, and altered ce ll-matrix interactions. Other 
features of chronic wounds that undoubtedly do playa role in the 
overall pathogenesis are nutrition, aging, and bacterial infection. 
Developing experimental approaches to address these and other 
biologic questions related to chronic wounds will be the first step in 
understanding the pathogenesis of chronic wounds. 
SlIpported jll part by NIH grall t AGI0998. 
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